Determine the Relationship Between Circadian Rhythms and Nocturnal Asthma
| Status: | Completed |
|---|---|
| Conditions: | Asthma |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - 60 |
| Updated: | 2/7/2015 |
| Start Date: | January 2009 |
| End Date: | December 2011 |
| Contact: | Brandon S. Lu, MD, MS |
| Email: | brandon-lu@northwestern.edu |
| Phone: | 312-503-1526 |
Circadian Rhythms and Nocturnal Asthma
Asthma is a disease that affects the lungs. Symptoms include repeated episodes of wheezing,
breathlessness, chest tightness, and nighttime or early morning coughing. Some people with
asthma experience worse symptoms at night, which is known as nocturnal asthma (NA). The
reason for the decline in lung function at night in some asthmatics is not well understood,
but it may be linked to the human biological clock, which controls daily activity and sleep
rhythms. To determine whether differences in biological clocks relate to worsening nocturnal
lung function, this study will evaluate the circadian rhythms of people with NA, people with
non-nocturnal asthma, and healthy people.
breathlessness, chest tightness, and nighttime or early morning coughing. Some people with
asthma experience worse symptoms at night, which is known as nocturnal asthma (NA). The
reason for the decline in lung function at night in some asthmatics is not well understood,
but it may be linked to the human biological clock, which controls daily activity and sleep
rhythms. To determine whether differences in biological clocks relate to worsening nocturnal
lung function, this study will evaluate the circadian rhythms of people with NA, people with
non-nocturnal asthma, and healthy people.
Nocturnal worsening of asthma, frequently called NA, is a common problem among some people
with asthma and one that leads to increased morbidity and mortality. It is still unknown why
lung function worsens at night in some asthmatics and not others. There is a possible
relationship between NA, biological clocks, and circadian rhythms, but more research is
needed to understand this relationship. Although the diurnal nature of NA has been shown
repeatedly in studies, circadian rhythms have not yet been implicated as a related factor.
This study will examine the pathophysiology of NA as it relates to circadian biology and
will specifically explore physiological and molecular aspects.
This study will include people with asthma, people with NA, and healthy people. Potential
participants will attend a screening visit to assess general health and severity of asthma,
if present. They will also complete 2 weeks of diary recordings of their daily symptoms and
airway function.
Eligible participants will then attend two study visits. The first study visit will last 1
hour and may include a methacholine challenge and bronchodilator testing, both of which will
measure lung function. For 2 weeks before the second study visit, participants will keep
records of their sleep patterns. The second study visit will be a hospital stay that will
last for 2.5 days. While in the hospital, participants will undergo periodic blood draws and
lung function testing. During waking hours, participants will remain quietly awake. During
the first night, participants will be monitored while they sleep. During the second night,
participants will stay awake for 28 hours, which will continue into the third day. Then, on
the third day, participants will sleep for 8 hours while again being monitored. Upon waking,
participants will be given a regular meal and discharged.
with asthma and one that leads to increased morbidity and mortality. It is still unknown why
lung function worsens at night in some asthmatics and not others. There is a possible
relationship between NA, biological clocks, and circadian rhythms, but more research is
needed to understand this relationship. Although the diurnal nature of NA has been shown
repeatedly in studies, circadian rhythms have not yet been implicated as a related factor.
This study will examine the pathophysiology of NA as it relates to circadian biology and
will specifically explore physiological and molecular aspects.
This study will include people with asthma, people with NA, and healthy people. Potential
participants will attend a screening visit to assess general health and severity of asthma,
if present. They will also complete 2 weeks of diary recordings of their daily symptoms and
airway function.
Eligible participants will then attend two study visits. The first study visit will last 1
hour and may include a methacholine challenge and bronchodilator testing, both of which will
measure lung function. For 2 weeks before the second study visit, participants will keep
records of their sleep patterns. The second study visit will be a hospital stay that will
last for 2.5 days. While in the hospital, participants will undergo periodic blood draws and
lung function testing. During waking hours, participants will remain quietly awake. During
the first night, participants will be monitored while they sleep. During the second night,
participants will stay awake for 28 hours, which will continue into the third day. Then, on
the third day, participants will sleep for 8 hours while again being monitored. Upon waking,
participants will be given a regular meal and discharged.
Inclusion Criteria for People with Asthma:
- A physician diagnosis of asthma, consistent clinical history, and either 1) airway
hyperresponsiveness indicated by a 20% or greater decrease in FEV1 in response to
inhalation of methacholine at 8 mg/mL or less, or 2) bronchodilator-responsive
expiratory airflow limitation (if FEV1 less than 70% of predicted value or less than
1.5 L, improving at least 200 mL and 12% in response to 180 μg of albuterol aerosol).
Patients with NA should meet the above criteria and demonstrate an overnight decrease
in peak flow of 20% or greater on at least four of seven nights at home.
Inclusion Criteria for all Participants:
- Able to follow directions
Exclusion Criteria for Participants with Asthma:
- Use of oral steroids within 2 weeks of study entry
- Use of cromolyn, leukotriene antagonist, or theophylline within 1 week of study entry
- History of cognitive or other neurological disorder
- Active symptoms of DSM-IV criteria for any major psychiatric disorder, alcohol
abuse, or substance abuse
- History of, or concurrent, unstable or serious medical illness
- Shift work
- History or evidence of chronic obstructive pulmonary disease (COPD)
- Tobacco smoking within the last month, or history of smoking greater than 5
pack-years
- Pregnancy or the desire to become pregnant during the study period
- Hematocrit less than 30
- Worsening or unstable asthma that requires use of a bronchodilator for more than four
times a day
Exclusion Criteria for all Participants:
- History of obstructive sleep apnea or a body mass index more than 36, or other sleep
disorder as assessed by questioning or polysomnography (PSG)
- History of cognitive or other neurological disorder
- Currently meets DSM-IV criteria for any major psychiatric disorder, alcohol abuse, or
substance abuse (as assessed by an interview)
- Concurrent unstable or serious medical illness (other than asthma)
- Current use of psychoactive medications, including antidepressants, anxiolytics,
neuroleptics, anticonvulsants, hypnotics, and stimulant medications
- Shift work
- A daily caffeine intake greater than 4 cups per day
- Smoking
- Pregnancy or the desire to become pregnant during the study period
- Atrial fibrillation or paced heart rhythm
We found this trial at
1
site
Northwestern University Northwestern is recognized both nationally and internationally for the quality of its educational...
Click here to add this to my saved trials
